Antibe Therapeutics Inc(Pre-Merger) T.ATE

Thinking out loud

[AllinATE]

Shouldn't trials be starting this week?
I wonder when the commercial study will be relased?
Also aren't they supposed to reveal IBD candidate in Q4?

[MrMugsy]

AllinATE - trials are supposed to start by 28th - not sure when they'd news release the first enrollment. Could release information on the study this week - OR - do they do a combo news release ?  IBD update ... by my estimate ... late in the year.  A 352 update could come before the IBD update ... or again ... could they package a 352/IBD update together ?  Hard to tell. So

[TheMadMonk]

AllinATE,   Please note that while the P2 molar trial is scheduled to start this week on the 28th, Dan did mention that it could be delayed a couple days.  The independent laboratory that tests and certifies the drugs to be used in the trial has been backed up and there is the chance that the start date of the trial may be delayed a few days.  If that happens don't

[MrMugsy]

Timing for the commercial study update is likely tied to P2 start and first enrollment (study pushed out as well).  Since we didn't get either by Friday - highly likely we get it next week - assuming no serious delay.  Let's get this show on the road !

[Inthepez]

If not mistaken this molar study will be on healthy patients. Shouldn't see any issues SE wise in acute that's not a nocebo (opposite of placebo effect) 

[MrMugsy]

Agreed - we shouldn't see any odd side-effects but we do have something different this time around. I am assuming we will have a very high load dose - so - curious if that could have any strange effect on the body.  Hoping they have already figured that out. In terms of LTE's - we are time-limiting and self-correcting ... good controls to have in place when you're going after